First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Shares Down 0.1% - Here's What Happened

Key Points

• The share price of the First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) fell by 0.1% during trading, closing at GBX 1,599.19 ($21.43).
• Trading volume was exceptionally low, with only 1 share exchanged, compared to the average session volume of 7,348 shares.
• The ETF has a market cap of £656.01 million and a P/E ratio of -1,453.81, indicating significant financial context for potential investors.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - )'s share price fell 0.1% during trading on Friday . The stock traded as low as GBX 1,599.19 ($21.43) and last traded at GBX 1,599.19 ($21.43). 1 shares traded hands during trading, a decline of 100% from the average session volume of 7,348 shares. The stock had previously closed at GBX 1,600.80 ($21.45).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance

The company has a 50-day moving average of GBX 1,560.25 and a 200 day moving average of GBX 1,512.44. The firm has a market cap of £656.01 million and a P/E ratio of -1,453.81.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.